Production (Stage)
MedMira Inc.
MIR.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -30.78% | -55.86% | -47.93% | 78.41% | -23.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -30.78% | -55.86% | -47.93% | 78.41% | -23.24% |
| Cost of Revenue | -12.17% | -22.38% | -4.50% | 55.27% | 8.10% |
| Gross Profit | 1.69% | -15.19% | -33.30% | -49.15% | -40.21% |
| SG&A Expenses | 13.92% | 49.69% | 24.63% | 130.96% | -39.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.01% | 67.70% | 55.61% | 87.98% | -7.47% |
| Operating Income | -15.53% | -103.62% | -76.02% | -88.74% | 4.82% |
| Income Before Tax | -20.35% | -92.96% | -65.77% | -18.90% | -31.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.35% | -92.96% | -65.77% | -18.90% | -31.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.35% | -92.96% | -65.77% | -18.90% | -31.98% |
| EBIT | -15.53% | -103.62% | -76.02% | -88.74% | 4.82% |
| EBITDA | -13.20% | -112.17% | -79.60% | -89.50% | 5.57% |
| EPS Basic | -25.00% | -100.00% | -75.00% | -20.00% | -33.33% |
| Normalized Basic EPS | -20.00% | -100.00% | -60.00% | -33.33% | -25.00% |
| EPS Diluted | -25.00% | -100.00% | -87.50% | 0.00% | -14.29% |
| Normalized Diluted EPS | -20.00% | -100.00% | -60.00% | -33.33% | -25.00% |
| Average Basic Shares Outstanding | 0.00% | 0.52% | 0.61% | 0.61% | 0.61% |
| Average Diluted Shares Outstanding | 0.00% | 0.52% | 0.61% | 0.61% | 0.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |